Database Release 2020.2

We are pleased to have been able to make an expeditious database release (version 2020.2), following on from our last update in March 2020 in order to make public new curation specifically related to SARS-CoV-2.

Content Updates

  • GtoPdb now includes a new SARS-Cov-2 protein family which includes 13 members and is included under ‘anti-infective targets’ in our hierarchy
  • The new targets in the SARS-CoV-2 protein family have been mapped to UniProt accessions were possible. Because so little is yet understood about SARS-CoV-2 at the molecular level, much of what is curated for these proteins has been predicted and/or extrapolated from what is known about SARS-CoV and MERS-CoV. We will of course update the pages as and when new data are published.
  • Several new compounds, relevant to SARS-CoV-2 have now been added, including PRD_002214 and compound 13b (virus main protease inhibitors), otamixaban and I-432 (potential TMPRSS2 inhibitors), and β-D-N4-hydroxycytidine (a broad spectrum antiviral compound).

The Guide to Pharmacology coronavirus information page continues to be updated on a regular basis to capture the latest pharmacological strategies under investigation to mitigate against COVID-19.

 

 

Posted in Uncategorized

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: